Details for New Drug Application (NDA): 203825
✉ Email this page to a colleague
The generic ingredient in NEBIVOLOL HYDROCHLORIDE is nebivolol hydrochloride. There are fourteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the nebivolol hydrochloride profile page.
Summary for 203825
Tradename: | NEBIVOLOL HYDROCHLORIDE |
Applicant: | Hetero Labs Ltd Iii |
Ingredient: | nebivolol hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 203825
Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for 203825
Suppliers and Packaging for NDA: 203825
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NEBIVOLOL HYDROCHLORIDE | nebivolol hydrochloride | TABLET;ORAL | 203825 | ANDA | Camber Pharmaceuticals, Inc. | 31722-585 | 31722-585-01 | 100 TABLET in 1 BOTTLE (31722-585-01) |
NEBIVOLOL HYDROCHLORIDE | nebivolol hydrochloride | TABLET;ORAL | 203825 | ANDA | Camber Pharmaceuticals, Inc. | 31722-585 | 31722-585-30 | 30 TABLET in 1 BOTTLE (31722-585-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 2.5MG BASE | ||||
Approval Date: | Nov 3, 2020 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Nov 3, 2020 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Nov 3, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription